Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system

Antioxidants and Redox Signaling

Volumn 18, Issue 9, 2013, Pages 1042-1052

  Burgoyne, Joseph R ^a   Oka, Shin Ichi ^b   Ale Agha, Niloofar ^c   Eaton, Philip ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HYDROGEN PEROXIDE; PROTEIN KINASE;

CARDIOVASCULAR SYSTEM; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOVASCULAR SYSTEM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYSTEINE; HOMEOSTASIS; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; METHIONINE; MODELS, CARDIOVASCULAR; OXIDATION-REDUCTION; OXIDOREDUCTASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 84874041662     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4817     Document Type: Review

References (69)

1. Alverdi V, Mazon H, Versluis C, Hemrika W, Esposito G, van den Heuvel R, Scholten A, and Heck AJ. cGMP-binding prepares PKG for substrate binding by disclosing the C-terminal domain. J Mol Biol 375: 1380-1393, 2008.
2. Antunes F and Cadenas E. Estimation of H2O2 gradients across biomembranes. FEBS Lett 475: 121-126, 2000.
3. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, and Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1: 11-14, 1986.
4. Benovic JL, Bouvier M, Caron MG, and Lefkowitz RJ. Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annu Rev Cell Biol 4: 405-428, 1988.
5. Biteau B, Labarre J, and Toledano MB. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphir-edoxin. Nature 425: 980-984, 2003.
6. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297: 842-857, 2007.
7. Brennan JP, Bardswell SC, Burgoyne JR, Fuller W, Schroder E, Wait R, Begum S, Kentish JC, and Eaton P. Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem 281: 21827-21836, 2006.
8. Brennan JP, Wait R, Begum S, Bell JR, Dunn MJ, and Eaton P. Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J Biol Chem 279: 41352-41360, 2004.
9. Browning DD, Mc Shane M, Marty C, and Ye RD. Functional analysis of type 1alpha cGMP-dependent protein kinase using green fluorescent fusion proteins. J Biol Chem 276: 13039-13048, 2001.
10. Budanov AV, Sablina AA, Feinstein E, Koonin EV, and Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304: 596-600, 2004.
11. Burgoyne JR and Eaton P. Transnitrosylating nitric oxide species directly activate type I protein kinase A, providing a novel adenylate cyclase-independent cross-talk to beta-ad-renergic-like signaling. J Biol Chem 284: 29260-29268, 2009.
12. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schroder E, Browning DD, and Eaton P. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317: 1393-1397, 2007.
13. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, and Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8: 691-728, 2006.
14. Charles RL, Burgoyne JR, Mayr M, Weldon SM, Hubner N, Dong H, Morisseau C, Hammock BD, Landar A, and Eaton P. Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J(2) controls coronary hypoxic vasodilation. Circ Res 108: 324-334, 2011.
15. Cohen MS, Hadjivassiliou H, and Taunton J. A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. Nat Chem Biol 3: 156-160, 2007.
16. de Pina MZ, Vazquez-Meza H, Pardo JP, Rendon JL, Villa-lobos-Molina R, Riveros-Rosas H, and Pina E. Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin. J Biol Chem 283: 12373-12386, 2008.
17. Dick DJ, Harrison FG, Okane PD, and Halliwell OT. Preconditioning of mechanically induced premature ventricular beats in the isolated rabbit heart. J Physiol-London 459: P509, 1993.
18. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
19. First EA and Taylor SS. Induced interchain disulfide bonding in cAMP-dependent protein kinase II. J Biol Chem 259: 4011-4014, 1984.
20. Forman HJ. Use and abuse of exogenous H2O2 in studies of signal transduction. Free Radic Biol Med 42: 926-932, 2007.
21. Gitler C, Zarmi B, and Kalef E. General method to identify and enrich vicinal thiol proteins present in intact cells in the oxidized, disulfide state. Anal Biochem 252: 48-55, 1997.
22. He BJ, Joiner ML, Singh MV, Luczak ED, Swaminathan PD, Koval OM, Kutschke W, Allamargot C, Yang J, Guan X, Zimmerman K, Grumbach IM, Weiss RM, Spitz DR, Sig-mund CD, Blankesteijn WM, Heymans S, Mohler PJ, and Anderson ME. Oxidation of CaMKII determines the car-diotoxic effects of aldosterone. Nat Med 17: 1610-1618, 2011.
23. Hering D, Esler MD, Krum H, Mahfoud F, Bohm M, Sobotka PA, and Schlaich MP. Recent advances in the treatment of hypertension. Expert Rev Cardiovasc Ther 9: 729-744, 2011.
24. Hess DT, Matsumoto A, Kim SO, Marshall HE, and Stamler JS. Protein S-nitrosylation: Purview and parameters. Nat Rev Mol Cell Biol 6: 150-166, 2005.
25. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, and Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5: 1135-1142, 1999.
26. Horoz M, Bolukbas C, Bolukbas FF, Aslan M, Koylu AO, Selek S, and Erel O. Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis 6: 114, 2006.
27. Hudmon A and Schulman H. Structure-function of the multifunctional Ca2+/calmodulin-dependent protein ki-nase II. Biochem J 364: 593-611, 2002.
28. Humphries KM, Juliano C, and Taylor SS. Regulation of cAMP-dependent protein kinase activity by glutathionyla-tion. J Biol Chem 277: 43505-43511, 2002.
29. Hyslop PA, Zhang Z, Pearson DV, and Phebus LA. Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: Correlation with the cytotoxic potential of H2O2 in vitro. Brain Res 671: 181-186, 1995.
30. Jonsson TJ, Johnson LC, and Lowther WT. Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace. Nature 451: 98-101, 2008.
31. Kamata H, Honda S, Maeda S, Chang L, Hirata H, and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP ki-nase phosphatases. Cell 120: 649-661, 2005.
32. Kim C, Cheng CY, Saldanha SA, and Taylor SS. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation. Cell 130: 1032-1043, 2007.
33. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, and Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 124: 1373-1380, 2003.
34. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, and Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: Role of heredity, gender, and ethnicity. Hypertension 36: 878-884, 2000.
35. Lacy F, O'Connor DT, and Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and nor-motensive subjects at genetic risk of hypertension. J Hy-pertens 16: 291-303, 1998.
36. Leitch JM, Yick PJ, and Culotta VC. The right to choose: Multiple pathways for activating copper, zinc superoxide dismutase. J Biol Chem 284: 24679-24683, 2009.
37. Leon DA, Herberg FW, Banky P, and Taylor SS. A stable alpha-helical domain at the N terminus of the RIalpha sub-units of cAMP-dependent protein kinase is a novel dimer-ization/docking motif. J Biol Chem 272: 28431-28437, 1997.
38. Maller C, Schroder E, and Eaton P. Glyceraldehyde 3-phosphate dehydrogenase is unlikely to mediate hydrogen peroxide signaling: Studies with a novel anti-dimedone sulfenic acid antibody. Antioxid Redox Signal 14: 49-60, 2011.
39. Mathew R. Pulmonary hypertension: Current therapy and future prospects. Cardiovasc Hematol Agents Med Chem 9: 165-182, 2011.
40. Monken CE and Gill GN. Structural analysis of cGMP-dependent protein kinase using limited proteolysis. J Biol Chem 255: 7067-7070, 1980.
41. Nemoto S and Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450-2452, 2002.
42. Ogura Y and Yamazaki I. Steady-state kinetics of the cata-lase reaction in the presence of cyanide. J Biochem 94: 403-408, 1983.
43. Osborne BW, Wu J, McFarland CJ, Nickl CK, Sankaran B, Casteel DE, Woods VL, Jr., Kornev AP, Taylor SS, and Dostmann WR. Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication. Structure 19: 1317-1327, 2011.
44. Palomeque J, Rueda OV, Sapia L, Valverde CA, Salas M, Petroff MV, and Mattiazzi A. Angiotensin II-induced oxi-dative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species. Circ Res 105: 1204-1212, 2009.
45. Peskin AV, Low FM, Paton LN, Maghzal GJ, Hampton MB, and Winterbourn CC. The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxi-dants and thiol reagents. J Biol Chem 282: 11885-11892, 2007.
46. Prysyazhna O, Rudyk O, and Eaton P. Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med 18: 286-290, 2012.
47. Richie-Jannetta R, Busch JL, Higgins KA, Corbin JD, and Francis SH. Isolated regulatory domains of cGMP-dependent protein kinase Ialpha and Ibeta retain dimerization and native cGMP-binding properties and undergo isoform-specific conformational changes. J Biol Chem 281: 6977-6984, 2006.
48. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
49. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, and Barford D. Redox regulation of protein ty-rosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423: 769-773, 2003.
50. Sarma GN, Kinderman FS, Kim C, von Daake S, Chen L, Wang BC, and Taylor SS. Structure of D-AKAP2:PKA RI complex: Insights into AKAP specificity and selectivity. Structure 18: 155-166, 2010.
51. Schröder E, Brennan JP, and Eaton P. Cardiac peroxiredox-ins undergo complex modifications during cardiac oxidant stress. Am J Physiol (Heart) 295: 425-433, 2008.
52. Schroder E and Eaton P. Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: Issues and considerations. Curr Opin Pharmacol 8: 153-159, 2008.
53. Skelding KA and Rostas JA. Regulation of CaMKII in vivo: The importance of targeting and the intracellular microen-vironment. Neurochem Res 34: 1792-1804, 2009.
54. Song YH, Cho H, Ryu SY, Yoon JY, Park SH, Noh CI, Lee SH, and Ho WK. L-type Ca(2+) channel facilitation mediated by H(2)O(2)-induced activation of CaMKII in rat ventricular myocytes. J Mol Cell Cardiol 48: 773-780, 2010.
55. Song YH, Choi E, Park SH, Lee SH, Cho H, Ho WK, and Ryu SY. Sustained CaMKII activity mediates transient oxidative stress-induced long-term facilitation of L-type Ca(2 +) current in cardiomyocytes. Free Radic Biol Med 51: 1708-1716, 2011.
56. Suematsu M, Schmid-Schonbein GW, Chavez-Chavez RH, Yee TT, Tamatani T, Miyasaka M, Delano FA, and Zweifach BW. In vivo visualization of oxidative changes in micro-vessels during neutrophil activation. Am J Physiol 264: H881-891, 1993.
57. Surks HK. cGMP-dependent protein kinase I and smooth muscle relaxation: A tale of two isoforms. Circ Res 101: 1078-1080, 2007.
58. Sznajder JI, Fraiman A, Hall JB, Sanders W, Schmidt G, Crawford G, Nahum A, Factor P, and Wood LD. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 96: 606-612, 1989.
59. Test ST and Weiss SJ. Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. J Biol Chem 259: 399-405, 1984.
60. Vigil D, Blumenthal DK, Taylor SS, and Trewhella J. The conformationally dynamic C helix of the RIalpha subunit of protein kinase A mediates isoform-specific domain reorganization upon C subunit binding. J Biol Chem 280: 35521-35527, 2005.
61. Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 4: 278-286, 2008.
62. Woo HA, Bae SH, Park S, and Rhee SG. Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins. Anti-oxid Redox Signal 11: 739-745, 2009.
63. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, and Rhee SG. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300: 653-656, 2003.
64. Wood ZA, Poole LB, and Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300: 650-653, 2003.
65. Yang KS, Kang SW, Woo HA, Hwang SC, Chae HZ, Kim K, and Rhee SG. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem 277: 38029-38036, 2002.
66. Zhang DX, Borbouse L, Gebremedhin D, Mendoza SA, Zinkevich NS, Li R, and Gutterman DD. H2O2-induced dilation in human coronary arterioles: Role of protein kinase G dimerization and large-conductance Ca2+-activated K + channel activation. Circ Res 110: 471-480, 2012.
67. Zhang J, Yang PL, and Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9: 28-39, 2009.
68. Zhu W, Woo AY, Yang D, Cheng H, Crow MT, and Xiao RP. Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem 282: 10833-10839, 2007.
69. Zick SK and Taylor SS. Interchain disulfide bonding in the regulatory subunit of cAMP-dependent protein kinase I. J Biol Chem 257: 2287-2293, 1982.